NBV-31207-87090
2 vaccinations
1 coded response
1 check-in
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 014 / MA
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-03
Dose 1 — Pfizer-BioNTech
-
2021-01-24
Dose 2 — Pfizer-BioNTech
-
2021-03-17
Registered in v-safe
-
2021-04-25
Survey response — 3 month, dose 2MedDRA: Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-25
Report sent to call center — 3 month, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-12-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Pfizer-BioNTech | |
| 2 | 2021-01-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-25 | Unsuccessful |
Free text
Release 7
Symptoms: Suffered a miscarriage a week after my second one dose I was 8 weeks pregnant
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release